Izabela Zakrocka
izabelazakrocka.bsky.social
Internist, nephrologist, transplantologist, Assistant Professor at Medical University of Lublin, #Glomcon 2021-2022 Fellow, ERA YNP Representative of Poland 🇵🇱, Board of Polish Young Transplantologists #NephSky #KidneyOmics #PharmKidney
👤 Joined on 10 November 2024
994
Followers
837
Following
51
Total Posts
📜 Kullanıcı Geçmişi
- 10 Kas 2024, 13:25
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@izabelazakrocka.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
An open-label randomized, noninferiority trial showed that intermittent HD was not noninferior to CRRT in critically ill adults with AKI. Death by day 90 occurred in 164 pts 63.1% & in 147 pts 53.5% respectively. Kaplan–Meier mortality estimates at day 90 were 63.3% & 53.6% (HR 1.30) nej.md/472QMel
Show Post
Diffuse Crescentic Fibrillary Glomerulonephritis With a Favorable Outcome - Kidney International Case Reports www.kicasereports.org/article/S311... March issue highlights
Show Post
Explore Genetics in Kidney Care The Genetics in Kidney Health Summit Recordings Showcase brings together established approaches, emerging research, and patient stories. Watch on demand: vimeo.com/showcase/124...
Show PostInfliximab for Drug-Induced Acute Interstitial Nephritis - Kidney International Case Reports www.kicasereports.org/article/S311... More from the March issue @kdjhaveri.bsky.social et al
Show PostCiltacabtagene Autoleucel in Monoclonal Gammopathy of Renal Significance - Kidney International Case Reports www.kicasereports.org/article/S311... From the March issue
Show Post